Quantbot Technologies LP Acquires Shares of 41,128 Heartflow, Inc. $HTFL

Quantbot Technologies LP bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 41,128 shares of the company’s stock, valued at approximately $1,207,000.

A number of other large investors have also recently made changes to their positions in HTFL. XXEC Inc. bought a new stake in Heartflow in the second quarter worth about $2,524,764,000. Sei Investments Co. grew its stake in shares of Heartflow by 342.5% during the first quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock valued at $1,631,000 after buying an additional 51,895 shares during the last quarter. Quantinno Capital Management LP purchased a new stake in shares of Heartflow in the first quarter worth approximately $1,734,000. Handelsbanken Fonder AB purchased a new stake in shares of Heartflow in the second quarter worth approximately $910,000. Finally, Walleye Capital LLC bought a new stake in shares of Heartflow during the 2nd quarter worth approximately $8,760,000.

Wall Street Analyst Weigh In

Several equities analysts have commented on the company. Morgan Stanley upped their price objective on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. boosted their target price on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Stifel Nicolaus upped their price target on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a report on Friday, August 14th. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, August 7th. Finally, William Blair began coverage on shares of Heartflow in a report on Monday, May 4th. They set an “outperform” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Insider Activity

In related news, insider Campbell Rogers sold 9,219 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the sale, the insider directly owned 86,459 shares of the company’s stock, valued at $3,564,704.57. This represents a 9.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 27,230 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $50.00, for a total transaction of $1,361,500.00. Following the transaction, the chief executive officer owned 360,814 shares in the company, valued at approximately $18,040,700. The trade was a 7.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 191,271 shares of company stock valued at $7,089,136 over the last 90 days. 7.70% of the stock is currently owned by corporate insiders.

Heartflow Stock Down 0.6%

Shares of NASDAQ:HTFL opened at $49.89 on Wednesday. The business’s 50 day moving average is $31.36 and its 200 day moving average is $28.63. The stock has a market cap of $4.34 billion and a P/E ratio of -27.26. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $51.19.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million during the quarter. The firm’s revenue was up 47.7% on a year-over-year basis. On average, sell-side analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.